SWDSOPLogo

Search within Therapeutic Immunology Group Web Site:


powered by Google

TIG/TAC Index

Tolerance Lab

Antibody Lab

FACS Machine Info

Other TIG Links

Therapeutic Antibody Centre

Dunn School of Pathology


List of monoclonal antibodies produced by TIG/Waldmann Group

Anti-mouse * Anti-canine * Anti-human

* Antibodies marked with asterisk are hybridomas with rat myeloma Y3/Ag1.2.3. Many of these antibodies and their hybridomas are also available for commercial licensing from Cambridge Enterprise. Where indicated, the hybridoma cell lines are also available from the European Collection of Cell Cultures (ECACC). If these cells cannot be obtained either from the ECACC or by contacting Cambridge Enterprise, and they are required for research/academic purposes only, then you may be able to obatin them using the hybridoma request form here.


Anti-mouse antibodies:

tr>
AntibodySpecificity Isotype (rat)CommentsAntibody/conjugates available commercially:Main applicationsECACC catalogue
YTS 109.8.1.1 Thy-1 IgMIn vitro depletion (+c') .....In vitro T cell depletion....
YTS 111.4.2*Thy-1 IgG2a...................
YTS 148.3.2.1*Thy-1 IgMIn vitro depletion (+c')..............
YTS 154.7.7.10* Thy-1 IgG2bIn vivo depleting Was Harlan, now: Serotec T+NK cell depletion in vivo87072285
YBM 29.2.1* Thy-1 IgG2cIn vitro depletion (+c').....In vitro T cell depletion/FACS11060806
YCTLD 45.1* Thy-1 IgG2c...................
YCTLD 160.101*Thy-1 IgG2c Mitogenic for T cells..............
NSM 46.7CD2IgG2aDomain 2.....FACS staining....
YTS 121.5.2*CD5 (Lyt-1) IgG2bIn vivo depleting Was Harlan, now: Serotec T cell depletion in vivo/FACS87072283
YTS 166.2.16* CD5 (Lyt-1) IgG2c...................
YTS 191.1.2* CD4 Epitope A IgG2bIn vivo depleting Serotec/CedarlaneCD4 subset depletion in vivo/FACS87072282
YTS 177.9.6.1*CD4 Epitope A IgG2aIn vivo blocking Serotec Peripheral tolerance induction/FACS stain11060819
YTA 3.1.2*CD4 Epitope B IgG2bIn vivo depleting Was Harlan, now: SerotecCD4 subset depletion in vivo/FACS89040603
YTS 169.4.2.1*CD8 (Lyt-2) IgG2bIn vivo depletingSerotec/Cedarlane CD8 subset depletion in vivo/FACS87072284
YTS 105.18.10*CD8 (Lyt-2) IgG2aIn vivo blockingSerotec CD8 T cell blockade in vivo/FACS stain11060802
YTS 156.7.7*CD8 (Lyt-3) IgG2bIn vivo depleting Was Harlan, now: SerotecCD8 subset depletion in vivo/FACS89040604
YBM 15.1.6* CD11b IgG2b anti-CR3.....FACS staining89040602
YBM 6.1.10* CD11b IgG2a anti-CR3.....FACS staining89040601
YTS 213.1.1*CD18IgG2a(Does not block function) .....SerotecFACS staining11060803
YMSM 636.4CD30IgG2b.....Serotec Activation antigen (IL-4 dependent?)/FACS....
YBM 42.2.2* CD45 (pan)IgG2a..........FACS staining/Immunoppt./western blot etc.....
YW 62.3.20* CD45IgG2bSynergistic pairSerotec/CedarlaneFACS staining11072202
YTS 165.1*CD45IgG2bSynergistic pair.....Haemopoietic cell depletion (with YW 62.3)....
YW 13.1.1*CD45R?IgG2b ..........Sorting haemopoietic cell precursors....
YBM 10.14.2*HSA?IgG2c...................
YBM 5.10.4* HSA IgMHeat Stable Antigen .....Thymocyte subsets/depletion of B cells in vitro11060805
YTA 74.4.4* CD71IgG2aTransferrin Receptor Serotec Activation antigen/FACS staining11060804
YTA 94.8.10*MHC-IIIgG2b(IAk+IEk+?) ...................
YLAG 77.5 LAG-3 IgG2b.....Serotec Activation antigen (IFN-g dependent)/FACS....
YGITR 765.4.2GITR (TNFSFR18)IgG2b.....To be Advised T cell costimulation/FACS....
YGITR 860.14.7GITR (TNFSFR18)IgG2b.....To be Advised T cell costimulation/FACS....
YGL 386.2.2 GITRLigand IgG1.....To be Advised Antigen presenting cell function/FACS....

Anti-canine antibodies:

AntibodySpecificity Isotype (rat)CommentsAntibody/conjugates available commercially:Main applicationsECACC catalogue
YKIX 302.9.3*CD4 IgG2aIn vivo blocking SerotecImmunosuppression/FACS staining....
YKIX 322.3.2*CD5 IgG2a .....SerotecFACS staining (T cells)....
YCATE 55.9.1*CD8 IgG1 CD8 alphaSerotec FACS staining/blocking....
YKIX 490.6.4*CD11/18 IgG2cIn vitro blockadeSerotecFunctional studies....
YKIX 337.8.7*CD44IgG2a .....Serotec FACS staining....
YKIX 716.13.2* CD45(RB?) IgG2bIn vitro killing (synergy) SerotecFACS staining/haemopoietic cell depletion....
YKIX 753.22.2* CD45R(A?) IgG2bIn vitro killing (synergy) SerotecFACS staining/haemopoietic cell depletion....
YKIX 739.46* CLAW-HIgG2apossible CD59? SerotecComplement protection studies?....
YKIX 337.217*Thy-1 IgG2bCDw90Serotec FACS staining (T cells)....
YKIX 334.2.4*MHC-IIIgG2aBlocks MLR SerotecFACS staining/blocking....

Anti-human antibodies

*** These anti-human hybridoma cell lines are subject to various license restrictions. ***

AntibodySpecificity Isotype (rat)CommentsAntibody/conjugates available commercially:Main applicationsECACC catalogue
YNB 46.1.8 CD4 IgG1 Blocks functionSerotecFACS staining/blocking....
YTH 30.15CD7 IgG2b .....Serotec FACS staining11060807
YTC 182.20 CD8 IgG2bSynergistic pair Serotec FACS staining/in vitro depletion....
YTC 141.1HLCD8 IgG2bSynergistic pair Serotec FACS staining/in vitro depletion....
YTH 81.5 CD11a IgG2aBlocks functionSerotecFACS staining/blocking11072203
YFC 120.5CD16IgG2bBlocks functionSerotecFACS staining/blocking11060808
YFC 118.12 CD18IgG2bBlocks functionSerotecFACS staining/blocking11072204
YTH 906.9HLCD25IgG2bBlocks functionSerotecFACS staining/blocking11060809
YTH 913.12 CD28IgG2bBlocks functionSerotecFACS staining/blocking11060810
YTH 24.5 CD45IgG2b .....Serotec FACS staining....
YTH 80.103 CD45R(C?) IgG2b .....Serotec FACS staining11060811
YTH 66.9 CD52IgMCAMPATH-1M SerotecLymphocyte depletion/FACS staining....
YTH 34.5 CD52IgG2bCAMPATH-1G SerotecLymphocyte depletion/FACS staining....
YTH 53.1 CD59IgG2bMac inhibitorSerotecFACS staining/blocking11060813
YTH 71.3 CD66acd IgG2a .....Serotec FACS staining11072205
YTH 8.18 ndIgG2bNeutros/macs cytoplasm SerotecImmunohistology....
YTH 655* Human CD2IgG2bDeplete foxp3.hCD2+ mouse Treg See request formFACS/in vivo depletion....
YTH 862.2HLA-class I IgG2bCytotoxic/monomorphicSerotecFACS staining/blocking11060817
YTH 470.5beta2-micro IgG2bCytotoxicSerotecFACS staining/blocking....
YTH 89.1 Glycophorin A (CD235a)IgG2b........FACS staining11060814
YAML 501.4 CD45:all isoformsIgG2a........FACS staining/immunohistology11060812
YAML 555.6 HLA-DRIgG2a........FACS staining/immunohistology11060816
YTH 76.3 HLA-BIgG2a........FACS staining11060815

*** These anti-human hybridoma cell lines are subject to various license restrictions. ***


TIGLogo

"Developing short-term treatments for long-term outcomes"


Related topics:

Antibodies in therapy

Making mAbs in large (gram) amounts

A Guide to Tolerance

An Immunology Glossary


Last Updated 1st September 2014 by Steve Cobbold